Intrathecal Pumps Market Driven By tricumed Medizintechnik, FLOWONIX MEDICAL, Durect, Medallion Therapeutics

The intrathecal pumps market has been segmented and analyzed on the bases of type, application, and geography. Based on region, the market is segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. The report offers insights and in-depth analysis of the intrathecal pumps market emphasizing on various parameters such as market trends, technological advancements, and market dynamics; it also provides the competitive landscape analysis of leading Intrathecal Pumps market players across the world and the analysis of the COVID-19 impact across various regions.

The intrathecal pumps market is expected to reach US$ 513.24 million by 2028 from US$ 357.38 million in 2021; it is estimated to grow at a CAGR of 5.3% during 2021–2028.

Request for sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00005395/?utm_source=OpenPR&utm_medium=10144

Medtronic; Smiths Medical; FLOWONIX MEDICAL INC.; tricumed Medizintechnik GmbH; Teleflex Incorporated; Johnson and Johnson Services, Inc.; Durect Corporation; Medallion Therapeutics, Inc.; Abbott; Baxter International Inc.. are among the major players in the intrathecal pumps market.

The key companies are adopting inorganic and organic growth strategies to expand their global footprints and product portfolio to meet the rising demands for the intrathecal pumps. For instance, in June 2020, Medtronic plc launched Efficio, a cloud-based data management software used with the SynchroMed II intrathecal drug delivery system that allows physicians to effectively manage targeted drug delivery pump practices to treat patients with chronic pain and severe spasticity. Efficio allows them to manage patient data without using spreadsheets and ease the export of data into electronic medical records systems.

Programmable devices such as the Medtronic SynchroMed systems deliver specific volumes of medication intermittently. These systems are the first choice for providers as they allow the medication dose to be changed during the disease progression and/or the patients develop pain tolerance to the drug without invasive intervention. In the event of an actual or suspected drug overdose or implant failure, the pumps can be interrupted and deactivated without having to empty the drug reservoir. However, since it is battery-powered device, the life of the pump is typically 5–8 years, and a new pump is implanted through a surgical procedures. Furthermore, since the volume of a drug reservoir is often smaller than the reservoir in a constant rate device, it needs to be refilled regularly. The intrathecal pumps market players are launching new products.

In October 2019, Flowonix Medical, Inc. received approval from the US Food and Drug Administration (FDA) to market the Prometra II 40 mL Programmable Pump and its associated programmer software. The Prometra II 40 mL Programmable Pump is designed to operate identically to the previously approved 20 mL pump that has shown clinical benefits in many of the 7,000 patients, which were implanted with this pump globally. Thus, the increasing acceptance of programmable pumps by medical professionals is driving the market growth.

The intrathecal pumps market, by type, is segmented into constant rate pumps and programmable pumps. The constant rate pumps segment is projected to hold a larger share of the market in 2021; however, the programmable pumps segment is anticipated to register a higher CAGR of 6.1% during the forecast period.

The intrathecal pumps market, based on application, is segmented into chronic pain and spasticity management. In 2021, the chronic pain segment is estimated to hold a larger share of the market; however, the spasticity segment is expected to register a higher CAGR during the 2021–2028.

By Geography

North America
US
Canada
Mexico
Europe
France
Germany
Italy
UK
Spain
Rest of Europe
Asia Pacific (APAC)
China
India
South Korea
Japan
Australia
Rest of APAC
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Rest of MEA
South and Central America (SCAM)
Brazil
Argentina
Rest of SCAM

Buy Now @ https://www.theinsightpartners.com/buy/TIPRE00005395/?utm_source=OpenPR&utm_medium=10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors etc.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.